WallStreetZenWallStreetZen

NASDAQ: ACET
Adicet Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ACET past revenue growth

How has ACET's revenue growth performed historically?
Company
-100%
Industry
69.78%
Market
14.1%
ACET's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ACET's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ACET earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$105.3M
Current Profit Margin
0%

ACET Return on Equity

Current Company
-36%
Current Industry
-18%
Current Market
30.8%
ACET's Return on Equity (-36%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ACET announces earnings.

ACET Return on Assets

Current Company
-31.9%
Current Industry
0.9%
ACET is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ACET Return on Capital Employed

Current Company
-36.67%
Current Industry
14.1%
ACET has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ACET vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ACET$0.00-$99.38M-$105.29M-100.00%N/A
LCTX$11.85M-$24.10M-$23.56M+25.75%N/A
FENC$3.21M-$24.35M-$26.07M+334.67%N/A
CRMD$57.77k-$33.71M-$33.23M-28.68%N/A
AKBA$271.03M-$8.93M-$56.36M+5.61%N/A
View Top Biotech Stocks

Adicet Bio Earnings & Revenue FAQ

What were ACET's earnings last quarter?

On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q1 2023 earnings per share (EPS) of -$0.72, up 700% year over year. Total Adicet Bio earnings for the quarter were -$30.88 million. In the same quarter last year, Adicet Bio's earnings per share (EPS) was $0.12.

If you're new to stock investing, here's how to buy Adicet Bio stock.

What was ACET's earnings growth in the past year?

As of Q2 2023, Adicet Bio's earnings has grown year over year. Adicet Bio's earnings in the past year totalled -$105.29 million.

What was ACET's revenue last quarter?

On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q1 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Adicet Bio's revenue was $24.99 million.

What was ACET's revenue growth in the past year?

As of Q2 2023, Adicet Bio's revenue has grown -100% year over year. This is 169.78 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Adicet Bio's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.